The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
Open accessAbstract
BACKGROUNDGlioblastoma is associated with a poor prognosis in the elderly.Survival has been shown to increase among patients 70 years of age or younger when temozolomide chemotherapy is added to standard radiotherapy (60 Gy over a period of 6 weeks).In elderly patients, more convenient shorter courses of radiotherapy are commonly used, but the benefit of adding temozolomide to a shorter course of radiotherapy is unknown. METHODSWe conducted a trial involving patients 65 years of age or older with newly diagnosed glioblastoma.Patients were randomly assigned to receive either radiotherapy alone (40 Gy in 15 fractions) or radiotherapy with concomitant and adjuvant temozolomide. RESULTSA total of 562 patients underwent randomization, 281 to each group.The median age was 73 years (range, 65 to 90).The median overall survival was longer with radiotherapy plus temozolomide than with radiotherapy alone (9.3 months vs. 7.6 months; hazard ratio for death, 0.67; 95% confidence interval [CI], 0.56 to 0.80; P<0.001), as was the median progression-free survival (5.3 months vs. 3.9 months; hazard ratio for disease progression or death, 0.50; 95% CI, 0.41 to 0.60; P<0.001).Among 165 patients with methylated O 6 -methylguanine-DNA methyltransferase (MGMT) status, the median overall survival was 13.5 months with radiotherapy plus temozolomide and 7.7 months with radiotherapy alone (hazard ratio for death, 0.53; 95% CI, 0.38 to 0.73; P<0.001).Among 189 patients with unmethylated MGMT status, the median overall survival was 10.0 months with radiotherapy plus temozolomide and 7.9 months with radiotherapy alone (hazard ratio for death, 0.75; 95% CI, 0.56 to 1.01; P = 0.055; P = 0.08 for interaction).Quality of life was similar in the two trial groups. CONCLUSIONSIn elderly patients with glioblastoma, the addition of temozolomide to short-course radiotherapy resulted in longer survival than short-course radiotherapy alone.(Funded by the Canadian Cancer Society Research Institute and others; ClinicalTrials.govnumber, NCT00482677.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Self-citationOstrom, Q. T., Gittleman, H., Farah, P., Ondracek, A., Chen, Y., Wolinsky, Y., Stroup, N. E., Kruchko, C., & Barnholtz-Sloan, J. S. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not151 · Cited by 11,994
Ostrom, Q. T., Gittleman, H., Fulop, J., Liu, M., Blanda, R., Kromer, C., Wolinsky, Y., Kruchko, C., & Barnholtz-Sloan, J. S. (2015) · Neuro-Oncology · doi:10.1093/neuonc/nov189 · Cited by 2,139
Malmström, A., Grønberg, B. H., Marosi, C., Stupp, R., Frappaz, D., Schultz, H., Abacioglu, U., Tavelin, B., Lhermitte, B., Hegi, M. E., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70265-6 · Cited by 1,286
Wick, W., Platten, M., Meisner, C., Felsberg, J., Tabatabai, G., Simon, M., Nikkhah, G., Papsdorf, K., Steinbach, J. P., Sabel, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70164-x · Cited by 1,135
Self-citationRoa, W., Brasher, P. M. A., Bauman, G., Anthes, M., Bruera, E., Chan, A., Fisher, B., Fulton, D., Gulavita, S., Hao, C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.06.082 · Cited by 904
Self-citationRadiotherapy for Glioblastoma in the Elderly
Keime-Guibert, F., Chinot, O., Taillandier, L., Cartalat-Carel, S., Frenay, M., Kantor, G., Guillamo, J.-S., Jadaud, E., Colin, P., Bondiau, P.-Y., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065901 · Cited by 792
Self-citationPredictive impact of MGMT promoter methylation in glioblastoma of the elderly
Reifenberger, G., Hentschel, B., Felsberg, J., Schackert, G., Simon, M., Schnell, O., Westphal, M., Wick, W., Pietsch, T., Loeffler, M., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27385 · Cited by 252
Self-citationBrandes, A. A., Franceschi, E., Tosoni, A., Benevento, F., Scopece, L., Mazzocchi, V., Bacci, A., Agati, R., Calbucci, F., & Ermani, M. (2009) · Cancer · doi:10.1002/cncr.24406 · Cited by 224
Self-citationVlassenbroeck, I., Califice, S., Diserens, A.-C., Migliavacca, E., Straub, J., Di Stefano, I., Moreau, F., Hamou, M.-F., Renard, I., Delorenzi, M., et al. (2008) · The Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.070169 · Cited by 197
Patterns of care in elderly glioblastoma patients
Iwamoto, F. M., Reiner, A. S., Panageas, K. S., Elkin, E. B., & Abrey, L. E. (2008) · Annals of Neurology · doi:10.1002/ana.21521 · Cited by 193
Optimal management of elderly patients with glioblastoma
Laperrière, N., Weller, M., Stupp, R., Perry, J., Brandes, A. A., Wick, W., & van den Bent, M. J. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2012.05.008 · Cited by 156
Self-citationPatterns of care and outcomes among elderly individuals with primary malignant astrocytoma
Barnholtz‐Sloan, J. S., Williams, V. L., Maldonado, J. L., Shahani, D., Stockwell, H. G., Chamberlain, M. C., & Sloan, A. E. (2008) · Journal of neurosurgery · doi:10.3171/jns/2008/108/4/0642 · Cited by 144
Glantz, M., Chamberlain, M. C., Liu, Q., Litofsky, N. S., & Recht, L. D. (2003) · Cancer · doi:10.1002/cncr.11323 · Cited by 136
Chinot, O. L., Barrié, M., Frauger, É., Dufour, H., Figarella-Branger, D. F., Palmari, J., Braguer, D., Hoang‐Xuan, K., Moktari, K., Peragut, J. C., et al. (2004) · Cancer · doi:10.1002/cncr.20224 · Cited by 136
Self-citationLowry, J. K., Snyder, J. J., & Lowry, P. W. (1998) · Archives of Neurology · doi:10.1001/archneur.55.7.922 · Cited by 132
Minniti, G. C., Salvati, M., Arcella, A., Buttarelli, F. R., D’Elia, A., Lanzetta, G., Esposito, V., Scarpino, S., Enrici, R. M., & Giangaspero, F. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-010-0324-4 · Cited by 101
Up-front temozolomide in elderly patients with glioblastoma
Laigle–Donadey, F., Figarella-Branger, D. F., Chinot, O. L., Taillandier, L., Cartalat‐Carel, S., Honnorat, J., Kaloshi, G., Delattre, J., & Sanson, M. (2010) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-0110-3 · Cited by 47
Self-citationGlioblastoma in the elderly: making sense of the evidence
Mason, M., Laperrière, N., Wick, W., Reardon, D. A., Malmström, A., Hovey, E. J., Weller, M., & Perry, J. (2015) · Neuro-Oncology Practice · doi:10.1093/nop/npv027 · Cited by 28
Self-citation
Cited by
EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood
Weller, M., van den Bent, M., Preusser, M., Le Rhun, E., Tonn, J. C., Minniti, G., Bendszus, M., Balana, C., Chinot, O., Dirven, L., et al. (2021) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-00447-z · Cited by 2,048
Self-citationManagement of glioblastoma: State of the art and future directions
Tan, A. C., Ashley, D. M., López, G. Y., Malinzak, M., Friedman, H. S., & Khasraw, M. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21613 · Cited by 1,972
Primary brain tumours in adults
Lapointe, S., Perry, A., & Butowski, N. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30990-5 · Cited by 1,366
Current state of immunotherapy for glioblastoma
Lim, M., Xia, Y., Bettegowda, C., & Weller, M. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0003-5 · Cited by 1,365
Glioblastoma and Other Primary Brain Malignancies in Adults: A Review
Schaff, L. R., & Mellinghoff, I. K. (2023) · JAMA · doi:10.1001/jama.2023.0023 · Cited by 1,271
Metadata
- Authors
- Perry, J. R., Laperriere, N., O’Callaghan, C. J., Brandes, A. A., Menten, J., Phillips, C., Fay, M., Nishikawa, R., Cairncross, J. G., Roa, W., Osoba, D., Rossiter, J. P., Sahgal, A., Hirte, H., Laigle-Donadey, F., Franceschi, E., Chinot, O., Golfinopoulos, V., Fariselli, L., Wick, A., Feuvret, L., Back, M., Tills, M., Winch, C., Baumert, B. G., Wick, W., Ding, K., & Mason, W. P.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2017-03-16
- Volume
- 376
- Issue
- 11
- Pages
- 1027-1037
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2599750069
- Cited by
- 1,172
- References
- 19
- FWCI
- 55.14
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.